Related references
Note: Only part of the references are listed.Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
Victor Manuel Orellana-Noia et al.
BLOOD (2022)
Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
Sabela Bobillo et al.
HAEMATOLOGICA (2021)
Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma
Thomas A. Ollila et al.
BLOOD (2021)
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study
Adam S. Zayac et al.
HAEMATOLOGICA (2021)
Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma
Dominic P. Decker et al.
LEUKEMIA & LYMPHOMA (2020)
The prevention of central nervous system relapse in diffuse large B-cell lymphoma: a British Society for Haematology good practice paper
Pamela McKay et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications
George W. Wright et al.
CANCER CELL (2020)
Analytical evaluation of the clonoSEQ Assay for establishing measurable (minimal) residual disease in acute lymphoblastic leukemia, chronic lymphocytic leukemia, and multiple myeloma
Travers Ching et al.
BMC CANCER (2020)
Timing of high-dose methotrexate CNS prophylaxis in DLBCL: an analysis of toxicity and impact on R-CHOP delivery
Matthew R. Wilson et al.
BLOOD ADVANCES (2020)
Liquid biopsy in lymphoma: Molecular methods and clinical applications
Melita Cirillo et al.
CANCER TREATMENT REVIEWS (2020)
Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell Lymphoma
Reid W. Merryman et al.
BLOOD (2020)
Molecular tumor analysis and liquid biopsy: a feasibility investigation analyzing circulating tumor DNA in patients with central nervous system lymphomas
Anne-Katrin Hickmann et al.
BMC CANCER (2019)
Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis
V. Rimelen et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Optimization of CSF biological investigations for CNS lymphoma diagnosis
Marine Armand et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity
Toby A. Eyre et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
ClonoSEQ assay for the detection of lymphoid malignancies
Anna Monter et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2019)
Evaluation of cerebrospinal clonal gene rearrangement in newly diagnosed non-Hodgkin's lymphoma patients
Boaz Nachmias et al.
ANNALS OF HEMATOLOGY (2019)
Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL
Magdalena Klanova et al.
BLOOD (2019)
MYD88 p.(L265P) detection on cell-free DNA in liquid biopsies of patients with primary central nervous system lymphoma
Laura S. Hiemcke-Jiwa et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Advances in risk assessment and prophylaxis for central nervous system relapse in diffuse large B-cell lymphoma
David Qualls et al.
HAEMATOLOGICA (2019)
Unique genetic profiles from cerebrospinal fluid cell-free DNA in leptomeningeal metastases of EGFR-mutant non-small-cell lung cancer: a new medium of liquid biopsy
Y. S. Li et al.
ANNALS OF ONCOLOGY (2018)
Diagnostic markers for CNS lymphoma in blood and cerebrospinal fluid: a systematic review
Anouk van Westrhenen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence
Thomas A. Ollila et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma
Tarec Christoffer El-Galaly et al.
EUROPEAN JOURNAL OF CANCER (2018)
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
Jason D. Merker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma
David M. Kurtz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial
M. Gleeson et al.
ANNALS OF ONCOLOGY (2017)
Detection of Driver and Resistance Mutations in Leptomeningeal Metastases of NSCLC by Next-Generation Sequencing of Cerebrospinal Fluid Circulating Tumor Cells
Ben-Yuan Jiang et al.
CLINICAL CANCER RESEARCH (2017)
How I treat patients with aggressive lymphoma at high risk of CNS relapse
Collin K. Chin et al.
BLOOD (2017)
High-throughput sequencing for noninvasive disease detection in hematologic malignancies
Florian Scherer et al.
BLOOD (2017)
Diffuse large B-cell lymphoma genotyping on the liquid biopsy
Davide Rossi et al.
BLOOD (2017)
Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma
Mark Roschewski et al.
BLOOD (2016)
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
Elena I. Pentsova et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP
Norbert Schmitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA
Florian Scherer et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Noninvasive monitoring of diffuse large B-cell lymphoma by immunoglobulin high-throughput sequencing
David M. Kurtz et al.
BLOOD (2015)
Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study
Mark Roschewski et al.
LANCET ONCOLOGY (2015)
Detection of malignant B lymphocytes by PCR clonality assay using direct lysis of cerebrospinal fluid and low volume specimens
L. Liu et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2015)
Contribution of cerebrospinal fluid sCD19 levels to the detection of CNS lymphoma and its impact on disease outcome
Carmen Muniz et al.
BLOOD (2014)
Double hit lymphoma: the MD Anderson Cancer Center clinical experience
Yasuhiro Oki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma
Wyndham H. Wilson et al.
HAEMATOLOGICA (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma
R. Alvarez et al.
ANNALS OF ONCOLOGY (2012)
Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination
Giulia Benevolo et al.
BLOOD (2012)
Incidence and risk factors for central nervous system relapse in patients with diffuse large B-cell lymphoma: the impact of the addition of rituximab to CHOP chemotherapy
D. Villa et al.
ANNALS OF ONCOLOGY (2010)
Brain parenchyma involvement as isolated central nervous system relapse of systemic non-Hodgkin lymphoma: an International Primary CNS Lymphoma Collaborative Group report
Nancy D. Doolittle et al.
BLOOD (2008)
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
V. Boehme et al.
ANNALS OF ONCOLOGY (2007)
Confidence intervals for rank statistics: Somers' D and extensions
Roger Newson
STATA JOURNAL (2006)
Detection of central nervous system leukemia in children with acute lymphoblastic leukemia by real-time polymerase chain reaction
SR Pine et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2005)
Share Paper
